Any research on germ cells needs to be licensed by the Human Fertilisation and Embryology Authority (HFEA).
"The definition needs to be very clear, and security forces need to be able to conduct more stringent operations against such cells, the tracking and hunting down of sleeper cells needs to be dramatically improved," he said.
An alternative, by recruitment of endogenous cells, needs experimental evidence.
The elevated ROS in the cancer cells needs more efficient antioxidants to kill the cells.
Yet, the transposition efficiency, specifically in germinal cells, needs to be improved.
However, the impact of tumor-infiltrating myeloid cells needs better characterization.
Before using CSC-targeted CART cells for clinical cancer treatment, the effectiveness of these cells needs to be evaluated.
The output impedance of the current cells needs to have an acceptable minimum value to reduce distortion in the system.
However, the safety of these cells needs to be understood and improved for eventual widespread commercial applications.
However, the cost of these cells needs to be significantly reduced to make them a commercial success.
Microcirculatory dysfunction and dissociation between cerebral cells' needs and perfusion at several cerebral areas was found in an experimental sepsis model[7, 8].
